A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma

被引:11
|
作者
Zhao, Kai [1 ]
Li, Xiangyu [1 ]
Shi, Yuanxin [1 ]
Lu, Yun [1 ]
Qiu, Peng [1 ]
Deng, Zhengdong [1 ]
Yao, Wei [2 ]
Wang, Jianming [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Biliary & Pancreat Surg,Canc Res Ctr, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China
[3] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic adenocarcinoma; pyroptosis; lncRNAs; prognosis; tumor immune microenvironment; immunotherapy; CELL-DEATH; CANCER STATISTICS; PROMOTES; PATHWAY;
D O I
10.3389/fgene.2022.899496
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Globally, pancreatic adenocarcinoma (PAAD) is a common and highly devastating gastrointestinal malignancy that seriously threatens human health. Pyroptosis refers to an emerging form of programmed cell death that has been discovered in recent years, and studies have demonstrated that long non-coding RNA (lncRNA) may act as a moderator in the pyroptosis process of cancer cells. However, relevant explorations about lncRNAs and pyroptosis are still insufficient in PAAD. Therefore, our research is designed to make a comprehensive analysis of the potential values of pyroptosis-related lncRNAs in PAAD.Methods: By integrating the RNA-sequencing, somatic mutation, and copy number variation (CNV) datasets, as well as the clinicopathological features, we established and validated a risk signature based on pyroptosis-related lncRNAs, and comprehensively analyzed its clinical significance and the potential connection with the tumor immune microenvironment (TIME).Consequences: The genetic variation landscape displayed that the somatic mutations were rare while CNV changes were general and mainly concentrated on copy number amplification of these 52 pyroptosis-related genes. Subsequently, a risk signature consisting of 10 lncRNAs (TRAF3IP2-AS1, LINC00519, LINC01133, LINC02251, AC005332.6, AL590787.1, AC090114.2, TRPC7-AS1, MIR223HG, and MIR3142HG) was constructed and patients were divided into different subgroups according to the median risk score; patients with high-risk scores presented worse outcomes compared to those with low-risk scores in the training, testing, and entire cohorts. Furthermore, patients at low-risk scores possessed a higher infiltration abundance of immune cells compared with high-risk patients, which was consistent with the expression levels of lncRNAs between the high/low-risk groups. Drug sensitivity analysis showed that low-risk scores were related to anti-cancer agents like AICAR and Axitinib, whereas high-risk scores were connected with certain drugs such as AUY922. These results demonstrated that our risk signature could be used for prognosis prediction; additionally, it was also related to the TIME that might act as a potential indicator to instruct immunotherapeutic strategies.Conclusion: This work explored the significance of the risk model constructed by pyroptosis-related lncRNAs in prognosis prediction and its internal link with the immune microenvironment of PAAD. The results are expected to assist in the diagnosis, prognostic assessment, and management of patients with PAAD.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
    Qu, Guangzhen
    Wang, Dong
    Xu, Weiyu
    Guo, Wei
    FRONTIERS IN GENETICS, 2022, 13
  • [2] Analysis of Pyroptosis-Related Signature for Predicting Prognosis and Tumor Immune Microenvironment in Pancreatic Cancer
    Li, Lincheng
    Deng, Zhaoda
    Xiao, Zhaohui
    Zou, Wenbo
    Liu, Rong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] A Pyroptosis-Related Gene Signature Associated with Prognosis and Tumor Immune Microenvironment in Gliomas
    Zhou, Zunjie
    Xu, Jing
    Huang, Ning
    Tang, Jun
    Ma, Ping
    Cheng, Yuan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 4753 - 4769
  • [4] A pyroptosis-related gene signature for prognosis and immune microenvironment of pancreatic cancer
    Tao, Sifan
    Tian, Li
    Wang, Xiaoyan
    Shou, Yajun
    FRONTIERS IN GENETICS, 2022, 13
  • [5] A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer
    Yang, Jiani
    Wang, Chao
    Zhang, Yue
    Cheng, Shanshan
    Xu, Yanna
    Wang, Yu
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [6] A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma
    Zhong, Jia'nan
    Wang, Zheng
    Hounye, Alphonse Houssou
    Liu, Jing
    Zhang, Jianglin
    Qi, Min
    LIFE SCIENCES, 2022, 307
  • [7] Pyroptosis-related lncRNAs: A novel prognosis signature of colorectal cancer
    Cai, Xing
    Liang, Xiaoqing
    Wang, Kun
    Liu, Yin
    Hao, Mengdi
    Li, Huimin
    Dai, Xiaofang
    Ding, Lei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer
    Mo, Xiaocong
    Hu, Di
    Li, Yin
    Nai, Aitao
    Ma, Feng
    Bashir, Shoaib
    Jia, Guoxia
    Xu, Meng
    FRONTIERS IN GENETICS, 2022, 13
  • [9] Systematic Analysis of a Pyroptosis-Related Signature to Predict the Prognosis and Immune Microenvironment of Lower-Grade Glioma
    He, Yongze
    Cai, Yuxiang
    Liu, Jinsheng
    Ding, Haixia
    Li, Xiang
    Tian, Sufang
    Li, Zhiqiang
    CELLS, 2022, 11 (24)
  • [10] The pyroptosis-related signature predicts prognosis and influences the tumor immune microenvironment in dedifferentiated liposarcoma
    Chen, Wenjing
    Cheng, Jun
    Cai, Yiqi
    Wang, Pengfei
    Jin, Jinji
    OPEN MEDICINE, 2024, 19 (01):